RCOR1 and cancer: Unsurprisingly, the pharmacological targeting of CoREST in human cancer has become a subject of intense investigation, whereby strategies have been developed to target both individual members of the complex, or multiple cofactors simultaneously, in an attempt to recover tumour suppressor expression (25,26).